Clinical trial

Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI)

NCT00211380

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2003-08-01

PhaseNA

Study timeline

Study start (unknown)2003-08-01Date precision: month

Registry last updated2011-09-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Schizoaffective Disorderunresolved

Interventions

aripiprazoleDRUG · verified · RxNorm: aripiprazole

Sponsors & collaborators

Louisiana State University Health Sciences Center Shreveportlead sponsor

SAM Technology & The San Francisco Brain Research Institutecollaborator

Mapped research locations

ShreveportLouisiana, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00211380 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.